Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol and Aspirin in Acute Minor Stroke and TIA
NCT06522113Phase 4Completed
- Sponsor
- Incheon St. Mary's Hospital
- Start
- Jul 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Incheon St. Mary's Hospital. Started Jul 2019; status: completed.
02
Drugs
cilostazol
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT06522113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06522113.